FDA Clearance Tracker · K172312
eego amplifiers
Last checked: Nov 20, 2026Latest source record: Mar 30, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Mar 30, 2018
Substantially Equivalent
Time to decision
241 days
Received Aug 1, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K172312
- Device name
- eego amplifiers
- Applicant location
- Berlin, DE
- Received
- Aug 1, 2017
- Decided
- Mar 30, 2018
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Amplifier, Physiological Signal (GWL)
- Device class
- Class II
- Regulation
- 21 CFR 882.1835
- Specialty
- Neurology & Neurosurgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code GWL. The earliest in FDA's data is K771683, decided Sep 20, 1977.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K172312
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Eemagine Medical Imaging Solutions GmbH
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K240575 · Decided Nov 25, 2024 · 269 days after receipt
Device type: Electrode, Cutaneous (GXY) · Neurology & Neurosurgery
- visor2 system510(k)
K210109 · Decided Apr 8, 2022 · 444 days after receipt
Device type: Neurological Stereotaxic Instrument (HAW) · Neurology & Neurosurgery
- Neo510(k)
K192889 · Decided Jan 30, 2020 · 112 days after receipt
Device type: Amplitude-Integrated Electroencephalograph (OMA) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.